Found: 96
Select item for more details and to access through your institution.
Drug Exposure of Long-Acting Cabotegravir and Rilpivirine in Older People With Human Immunodeficiency Virus: A Pharmacokinetic Modeling Study.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 4, p. 1, doi. 10.1093/ofid/ofae171
- By:
- Publication type:
- Article
Guidance for the Interpretation of Long-Acting Cabotegravir and Rilpivirine Concentrations Based on Real-World Therapeutic Drug Monitoring Data and Documented Failures.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 2, p. 1, doi. 10.1093/ofid/ofae023
- By:
- Publication type:
- Article
Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 2, p. 477, doi. 10.1093/cid/ciae060
- By:
- Publication type:
- Article
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 1, p. 98, doi. 10.1093/cid/ciad495
- By:
- Publication type:
- Article
Leukocyte Count and Coronary Artery Disease Events in People With Human Immunodeficiency Virus: A Longitudinal Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 1969, doi. 10.1093/cid/ciad033
- By:
- Publication type:
- Article
Management of Drug-Drug Interactions Between Long-Acting Cabotegravir and Rilpivirine and Comedications With Inducing Properties: A Modeling Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 7, p. 1225, doi. 10.1093/cid/ciac901
- By:
- Publication type:
- Article
Coronary Artery Disease–Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 9, p. 1597, doi. 10.1093/cid/ciab521
- By:
- Publication type:
- Article
Prevalence of Potential Drug–Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 7, p. e2145, doi. 10.1093/cid/ciaa918
- By:
- Publication type:
- Article
Polypharmacy and Drug–Drug Interactions in People Living With Human Immunodeficiency Virus in the Region of Madrid, Spain: A Population-Based Study.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 2, p. 353, doi. 10.1093/cid/ciz811
- By:
- Publication type:
- Article
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 6, p. 742, doi. 10.1093/infdis/jiad179
- By:
- Publication type:
- Article
Telomere Length Declines in Persons With Human Immunodeficiency Virus Before Antiretroviral Therapy Start but Not After Viral Suppression: A Longitudinal Study Over >17 Years.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Placental transfer of antiretroviral drugs
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Polymorphisms in Human MDR1 (P-glycoprotein): Recent Advances and Clinical Relevance<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 1, p. 13, doi. 10.1016/j.clpt.2003.09.012
- By:
- Publication type:
- Article
Population pharmacokinetics and effects of efavirenz in patients with human immunodeficiency virus infection<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 1, p. 20, doi. 10.1067/mcp.2003.22
- By:
- Publication type:
- Article
Major revision version 12.0 of the European AIDS Clinical Society guidelines 2023.
- Published in:
- HIV Medicine, 2023, v. 24, n. 11, p. 1126, doi. 10.1111/hiv.13542
- By:
- Publication type:
- Article
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 849, doi. 10.1111/hiv.13268
- By:
- Publication type:
- Article
HIV and Aging - Perhaps Not as Dramatic as We Feared?
- Published in:
- 2018
- By:
- Publication type:
- journal article
Impact of Obesity on the Drug–Drug Interaction Between Dolutegravir and Rifampicin or Any Other Strong Inducers.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 7, p. 1, doi. 10.1093/ofid/ofad361
- By:
- Publication type:
- Article
Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 12, p. N.PAG, doi. 10.1093/ofid/ofz531
- By:
- Publication type:
- Article
Obesity Trends and Body Mass Index Changes After Starting Antiretroviral Treatment: The Swiss HIV Cohort Study.
- Published in:
- Open Forum Infectious Diseases, 2014, v. 1, n. 2, p. 1
- By:
- Publication type:
- Article
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 7, p. 979, doi. 10.1007/s00228-020-03060-2
- By:
- Publication type:
- Article
Variations of CYP3A activity induced by antiretroviral treatment in HIV-1 infected patients.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 60, n. 12, p. 865, doi. 10.1007/s00228-004-0855-8
- By:
- Publication type:
- Article
Sex Differences in Lopinavir Concentrations and Occurrence of Marked QTc Prolongation Episodes in Patients with COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Lactic acidosis and hyperlactatemia associated with lamivudine accumulation and sepsis in a kidney transplant recipient—a case report and review of the literature.
- Published in:
- AIDS Research & Therapy, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12981-021-00382-8
- By:
- Publication type:
- Article
Ageing with HIV: medication use and risk for potential drug-drug interactions.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Ageing with HIV: medication use and risk for potential drug–drug interactions.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2011, v. 66, n. 9, p. 2107
- By:
- Publication type:
- Article
Collaborative Challenges of Multi-Cohort Projects in Pharmacogenetics—Why Time Is Essential for Meaningful Collaborations.
- Published in:
- JMIR Formative Research, 2022, v. 6, n. 9, p. 1, doi. 10.2196/36759
- By:
- Publication type:
- Article
Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study.
- Published in:
- Infectious Diseases & Therapy, 2024, v. 13, n. 3, p. 609, doi. 10.1007/s40121-024-00935-0
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese Individuals.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 2, p. 277, doi. 10.1007/s40262-022-01194-3
- By:
- Publication type:
- Article
Repository Describing the Anatomical, Physiological, and Biological Changes in an Obese Population to Inform Physiologically Based Pharmacokinetic Models.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 9, p. 1251, doi. 10.1007/s40262-022-01132-3
- By:
- Publication type:
- Article
Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Drug–Drug Interaction Potential with Once-Weekly Isoniazid/Rifapentine (3HP) for the Treatment of Latent Tuberculosis Infection.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 3, p. 339, doi. 10.1007/s40262-021-01098-8
- By:
- Publication type:
- Article
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine.
- Published in:
- Clinical Pharmacokinetics, 2021, v. 60, n. 7, p. 835, doi. 10.1007/s40262-021-01005-1
- By:
- Publication type:
- Article
Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy.
- Published in:
- PLoS ONE, 2012, v. 7, n. 1, p. 1, doi. 10.1371/journal.pone.0029186
- By:
- Publication type:
- Article
Pharmacogenetics of Plasma Efavirenz Exposure after Treatment Discontinuation: An Adult AIDS Clinical Trials Group Study.
- Published in:
- Clinical Infectious Diseases, 2006, v. 42, n. 3, p. 401, doi. 10.1086/499364
- By:
- Publication type:
- Article
Development and validation of a multiplex UHPLC‐MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV
- Published in:
- Journal of Mass Spectrometry, 2020, v. 55, n. 6, p. 1, doi. 10.1002/jms.4506
- By:
- Publication type:
- Article
Switch from a ritonavir to a cobicistat containing antiretroviral regimen and impact on tacrolimus levels in a kidney transplant recipient.
- Published in:
- Virology Journal, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12985-023-02058-3
- By:
- Publication type:
- Article
Recommendations for Dosing of Repurposed COVID-19 Medications in Patients with Renal and Hepatic Impairment.
- Published in:
- Drugs in R&D, 2021, v. 21, n. 1, p. 9, doi. 10.1007/s40268-020-00333-0
- By:
- Publication type:
- Article
Prescribing Nirmatrelvir-Ritonavir: How to Recognize and Manage Drug-Drug Interactions.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Development of an evidence evaluation and synthesis system for drug-drug interactions, and its application to a systematic review of HIV and malaria co-infection.
- Published in:
- PLoS ONE, 2017, v. 12, n. 3, p. 1, doi. 10.1371/journal.pone.0173509
- By:
- Publication type:
- Article
Cardiovascular adverse effects of lopinavir/ritonavir and hydroxychloroquine in COVID-19 patients: Cases from a single pharmacovigilance centre.
- Published in:
- Global Cardiology Science & Practice, 2021, v. 2021, n. 2, p. 1, doi. 10.21542/gcsp.2021.11
- By:
- Publication type:
- Article
Population pharmacokinetic analysis of doravirine in real‐world people with HIV.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 4, p. 1058, doi. 10.1111/bcp.15975
- By:
- Publication type:
- Article
Intramuscular cabotegravir and rilpivirine concentrations after switching from efavirenz‐containing regimen.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 12, p. 3618, doi. 10.1111/bcp.15867
- By:
- Publication type:
- Article
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimen.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 9, p. 2739, doi. 10.1111/bcp.15754
- By:
- Publication type:
- Article
Clinically relevant bidirectional drug‐drug interaction between midostaurin and voriconazole.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2304, doi. 10.1111/bcp.15743
- By:
- Publication type:
- Article
Prescribing in COVID‐19 patients: Should we take into account inflammation?
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 3, p. 719, doi. 10.1111/bcp.14524
- By:
- Publication type:
- Article
Effect of ageing on antiretroviral drug pharmacokinetics using clinical data combined with modelling and simulation.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 2, p. 458, doi. 10.1111/bcp.14402
- By:
- Publication type:
- Article
COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 1, p. 212, doi. 10.1111/bcp.14358
- By:
- Publication type:
- Article
Cobicistat: A case of mislabelled drug‐drug interaction risk?
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 5, p. 834, doi. 10.1111/bcp.14262
- By:
- Publication type:
- Article